DFTX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Definium Therapeutics reported positive topline Phase 3 Panorama results for DT120 ODT in generalized anxiety disorderSep 14, 2026
- Definium Therapeutics reported positive topline Phase 3 Voyage results for DT120 ODT in generalized anxiety disorderAug 12, 2026
- A healthcare claims study published in CNS Spectrums reported high treatment switching, discontinuation, and care gaps among patients with generalized anxiety disorderJul 14, 2026
- Definium Therapeutics reported positive topline Phase 3 results for DT120 orally disintegrating tablet in major depressive disorderJun 22, 2026
- Definium Therapeutics doses first patient in second pivotal Phase 3 study of DT120 ODT for major depressive disorderMay 12, 2026